Literature DB >> 32936781

The FDA Metformin Label Change and Racial and Sex Disparities in Metformin Prescription among Patients with CKD Injury.

Mark Peter Rutkowski1.   

Abstract

Entities:  

Keywords:  FDA drug label; chronic kidney disease; clinical epidemiology; creatinine; disparities; estimated glomerular filtration rate; metformin

Year:  2020        PMID： 32936781      PMCID： PMC7608973          DOI： 10.1681/ASN.2020071061

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  3 in total

1.  Reconsidering the Consequences of Using Race to Estimate Kidney Function.

Authors:  Nwamaka Denise Eneanya; Wei Yang; Peter Philip Reese
Journal:  JAMA       Date:  2019-07-09       Impact factor: 56.272

2.  The FDA Metformin Label Change and Racial and Sex Disparities in Metformin Prescription among Patients with CKD.

Authors:  Jung-Im Shin; Yingying Sang; Alex R Chang; Stephan C Dunning; Josef Coresh; Lesley A Inker; Elizabeth Selvin; Shoshana H Ballew; Morgan E Grams
Journal:  J Am Soc Nephrol       Date:  2020-07-13       Impact factor: 10.121

Review 3.  Kidney Disease, Race, and GFR Estimation.

Authors:  Andrew S Levey; Silvia M Titan; Neil R Powe; Josef Coresh; Lesley A Inker
Journal:  Clin J Am Soc Nephrol       Date:  2020-05-11       Impact factor: 8.237
  3 in total
  1 in total

1.  Authors' Reply.

Authors:  Jung-Im Shin; Yingying Sang; Stephan C Dunning; Morgan E Grams
Journal:  J Am Soc Nephrol       Date:  2020-09-11       Impact factor: 10.121
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.